Haemonetics CorporationHAENYSE
Loading
Year-over-year earnings per share growth rate
Percentile
P59
Within normal range
vs 2Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 18.52% |
| Q3 2025 | 14.08% |
| Q2 2025 | -39.32% |
| Q1 2025 | 56.00% |
| Q4 2024 | 13.64% |
| Q3 2024 | -12.00% |
| Q2 2024 | 87.50% |
| Q1 2024 | -35.48% |
| Q4 2023 | 26.53% |
| Q3 2023 | -39.51% |
| Q3 2023 | 39.66% |
| Q1 2023 | -10.77% |
| Q4 2022 | 0.00% |
| Q4 2022 | 66.67% |
| Q3 2022 | 105.26% |
| Q1 2022 | -57.78% |
| Q1 2022 | 55.17% |
| Q4 2021 | 422.22% |
| Q3 2021 | 59.09% |
| Q1 2021 | -134.92% |
| Q4 2020 | -33.68% |
| Q3 2020 | 352.38% |
| Q2 2020 | -38.24% |
| Q1 2020 | -42.37% |
| Q4 2019 | -20.27% |
| Q3 2019 | 535.29% |
| Q2 2019 | -142.50% |
| Q1 2019 | 11.11% |
| Q4 2018 | 0.00% |
| Q3 2018 | 765.43% |
| Q2 2018 | -124.59% |
| Q1 2018 | 283.33% |
| Q4 2017 | -131.58% |
| Q3 2017 | 0.00% |
| Q3 2017 | 138.78% |
| Q1 2017 | -426.67% |
| Q4 2016 | -23.08% |
| Q4 2016 | 295.00% |
| Q3 2016 | -17.65% |
| Q1 2016 | 85.47% |